tiprankstipranks
Trending News
More News >
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market

Hansoh Pharmaceutical Group Company Limited (3692) Income Statement

Compare
4 Followers

Hansoh Pharmaceutical Group Company Limited Income Statement

Last quarter (Q4 2024), Hansoh Pharmaceutical Group Company Limited's total revenue was ¥5.76B, an increase of 16.32% from the same quarter last year. In Q4, Hansoh Pharmaceutical Group Company Limited's net income was ¥1.65B. See Hansoh Pharmaceutical Group Company Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 12.26B¥ 10.10B¥ 9.38B¥ 9.94B¥ 8.69B
Gross Profit
¥ 11.16B¥ 9.07B¥ 8.51B¥ 9.06B¥ 7.89B
Operating Expenses
¥ 7.12B¥ 6.23B¥ 5.84B¥ 5.97B¥ 4.95B
Depreciation and Amortization
¥ 401.35M¥ 366.38M¥ 344.60M¥ 278.47M¥ 233.27M
EBITDA
¥ 4.25B¥ 4.20B¥ 2.93B¥ 3.08B¥ 2.99B
Operating Income
¥ 4.03B¥ 2.84B¥ 2.61B¥ 2.82B¥ 2.77B
Other Income/Expenses
¥ 1.05B¥ 926.83M¥ 277.21M¥ 403.58M¥ 325.38M
Pretax Income
¥ 5.09B¥ 3.77B¥ 2.95B¥ 3.30B¥ 3.10B
Net Income
¥ 4.37B¥ 3.28B¥ 2.58B¥ 2.71B¥ 2.57B
Per Share Metrics
Basic EPS
¥ 0.74¥ 0.50¥ 0.44¥ 0.46¥ 0.44
Diluted EPS
¥ 0.73¥ 0.52¥ 0.44¥ 0.44¥ 0.44
Weighted Average Shares Outstanding
5.93B 6.27B 5.92B 5.92B 5.88B
Weighted Average Shares Outstanding (Diluted)
5.95B 6.02B 5.93B 6.00B 5.88B
Currency in CNY

Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis